Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Light-Based scanner could reveal hidden infections and oxygen levels in wounds

NCT ID NCT07646938

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a handheld device that uses special light to measure oxygen levels, detect bacteria, and check temperature in wounds. Doctors will use the images to guide cleaning procedures. The goal is to see if this extra information helps them decide how much tissue to remove. The study includes 20 adults with wounds larger than 1 cm².

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MolecuLightDX+ with OxySight Module (imaging device)
What this could lead to
If successful, this device could help doctors see wound infections and oxygen levels instantly, improving debridement decisions and wound care.
What could go wrong
This is a small, early feasibility study with only 20 participants, so results may not apply to all wounds or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

18 people

The number who actually took part.

Started

Mar 2026

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults 18 years and older with surface wounds.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female patients presenting with a wound * A wound is \> 1 cm2 in area * 18+ years old * Willing to consent Exclusion Criteria: * Contraindication to debridement * Undergoing radio- or chemotherapy * Wound located in a difficult to image location * Any condition deemed by the investigator to interfere with safety or data validity * Inability or unwillingness to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wounds are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SerenaGroup Monroeville

    Monroeville, Pennsylvania, 15146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.